Literature DB >> 2476018

Altered sympathetic system and adrenoceptors during the development of cardiac hypertrophy.

P K Ganguly1, S L Lee, R E Beamish, N S Dhalla.   

Abstract

Increasing experimental evidence suggests that the development of cardiac hypertrophy may involve the sympathetic system and associated receptor mechanisms. However, very little work has been done so far to understand changes in the sympathetic system and cardiac adrenoceptors soon after an increased work load is imposed on the heart. Accordingly rat hearts subjected to aortic banding-induced pressure overload were assessed 3, 7, and 14 days postoperatively. Sham-operated rats without aortic banding were used as a control group. Rats with aortic constriction had increases in heart rate, left ventricular systolic pressure, and total mechanical energy during the entire study period. The cardiac RNA level was increased without a significant increase in left ventricular mass on days 3 and 7 in aortic-banded animals; these results were associated with a decrease in the cardiac norepinephrine (NE) store and an increase in the plasma level of NE and dopamine beta-hydroxylase (DBH) activity. By day 14 a significant increase in left ventricular mass and the NE store were found; both plasma NE and DBH remained elevated. Catecholamines in other tissues such as the spleen and kidney were depleted in the banded group, whereas the dopamine level, particularly in the brain, was significantly higher during the entire study. Furthermore, the density of alpha-adrenoceptors was higher on day 3 of aortic banding, and a reciprocal correlation was evident between cardiac alpha- and beta-adrenoceptors on day 14; the density of beta-adrenoceptors was increased, whereas that of alpha-adrenoceptors was decreased in the banded group.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2476018     DOI: 10.1016/0002-8703(89)90267-6

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  8 in total

1.  123I-MIBG myocardial imaging in hypertensive patients: abnormality progresses with left ventricular hypertrophy.

Authors:  I Mitani; S Sumita; N Takahashi; H Ochiai; M Ishii
Journal:  Ann Nucl Med       Date:  1996-08       Impact factor: 2.668

2.  Chronic hemodynamic unloading regulates the morphologic development of newborn mouse hearts transplanted into the ear of isogeneic adult mice.

Authors:  M A Rossi
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

3.  Disruption of adenylyl cyclase type V does not rescue the phenotype of cardiac-specific overexpression of Galphaq protein-induced cardiomyopathy.

Authors:  Valeriy Timofeyev; Cliff A Porter; Dipika Tuteja; Hong Qiu; Ning Li; Tong Tang; Anil Singapuri; Pyung-Lim Han; Javier E Lopez; H Kirk Hammond; Nipavan Chiamvimonvat
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-08-13       Impact factor: 4.733

Review 4.  Iodine 123-labeled metaiodobenzylguanidine imaging in heart disease.

Authors:  P Merlet; H Valette; J L Dubois-Randé; K Mardon; F Pouillart; M L Bourachot; A Castaigne; A Syrota
Journal:  J Nucl Cardiol       Date:  1994 Mar-Apr       Impact factor: 5.952

5.  Observations on atrial natriuretic peptide, sympathetic activity and renal Ca2+ pump in diabetic and hypertensive rats.

Authors:  A Sahai; P K Ganguly
Journal:  Clin Auton Res       Date:  1993-04       Impact factor: 4.435

6.  Effect of angiotensin converting enzyme inhibitor on regression in cardiac hypertrophy.

Authors:  N Makino; H Matsui; K Masutomo; T Hata; T Yanaga
Journal:  Mol Cell Biochem       Date:  1993-02-17       Impact factor: 3.396

7.  Renal dopamine receptors are involved in the development of cardiac hypertrophy.

Authors:  P K Ganguly; K Mukherjee; A Sahai
Journal:  Mol Cell Biochem       Date:  1995-03-09       Impact factor: 3.396

Review 8.  Upregulation of Phospholipase C Gene Expression Due to Norepinephrine-Induced Hypertrophic Response.

Authors:  Paramjit S Tappia; Naranjan S Dhalla
Journal:  Cells       Date:  2022-08-11       Impact factor: 7.666

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.